Neurocrine
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.About NBIX
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids.
NBIX Key Statistics
Stock Snapshot
The current Neurocrine(NBIX) stock price is $132.25, with a market capitalization of 13.27B. The stock trades at a price-to-earnings (P/E) ratio of 28.32.
On 2026-03-01, Neurocrine(NBIX) stock traded between a low of $129.09 and a high of $132.77. Shares are currently priced at $132.25, which is +2.4% above the low and -0.4% below the high.
The Neurocrine(NBIX)'s current trading volume is 1.26M, compared to an average daily volume of 1.23M.
During the past year, Neurocrine(NBIX) stock moved between $84.23 at its lowest and $160.18 at its peak.
During the past year, Neurocrine(NBIX) stock moved between $84.23 at its lowest and $160.18 at its peak.
NBIX News
In February 2026, Neurocrine Biosciences reported that fourth-quarter 2025 revenue rose to US$805.5 million and net income to US$153.7 million, with full-year r...
Neurocrine Biosciences (NBIX) is back in focus after reporting fourth quarter and full year 2025 earnings, alongside fresh 2026 sales guidance for INGREZZA and...
Wolfe Research initiated coverage of Neurocrine (NBIX) with an Outperform rating and $160 price target The firm launched coverage of the neuroscience biotech se...
Analyst ratings
84%
of 31 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.